女性科技市场机会、成长动力、产业趋势分析及 2025-2034 年预测

2024 年全球女性科技市场价值为 602 亿美元，预计 2025 年至 2034 年期间的复合年增长率为 16%。 Femtech 是女性科技的缩写，专注于开发创新产品、服务和平台，以满足女性独特的医疗保健需求。这些包括生育、怀孕、生殖健康、更年期、性健康和一般健康的解决方案。尤其是在已开发国家，人们越来越依赖数位科技来管理女性健康，这极大地推动了市场的成长。

女性癌症、糖尿病、高血压等慢性病和精神健康问题日益增多，推动了对个人化、技术驱动型医疗保健的需求。 Femtech 提供客製化工具，帮助女性应对复杂的健康挑战，进一步促进市场发展。人们对以女性为中心的健康问题的认识不断提高，以及穿戴式和行动健康设备的发展，推动了对可获得且有针对性的解决方案的需求。先进技术融入女性日常医疗保健，鼓励更多女性采用数位平台，创造了强劲的市场动能。

从类型来看，2024 年女性科技市场规模估计为 602 亿美元，其中产品部分贡献 115 亿美元，预计 2025 年至 2034 年期间的成长率为 13.8%。个人化医疗解决方案需求的不断增长以及穿戴式装置和行动医疗技术的快速发展，正在提高产品的采用率。人们对妊娠併发症的认识不断提高，以及对监测和管理女性健康的创新工具的需求进一步支持了市场前景。在应用方面，女性科技分为怀孕和护理、生殖健康、骨盆和子宫保健、一般医疗保健和健康等。

生殖健康领域在 2024 年占据市场主导地位，收入达 264 亿美元，占有 43.9% 的份额。人们对生育、怀孕、月经和更年期相关健康问题的认识不断提高，加上讨论这些问题的开放程度不断提高，对专业生殖健康解决方案的需求也不断增加。先进的穿戴式装置、行动应用程式和远距医疗的结合改变了生殖健康管理，推动了市场的发展。

根据最终用途，市场分为直接面向消费者、医院、生育诊所、外科中心、诊断中心和其他。到 2024 年，直接面向消费者的市场规模将达到 195 亿美元，这得益于人们对可在家中使用的个人化医疗工具的偏好日益增长。越来越多的女性选择能够满足敏感健康需求同时又能确保隐私和便利的产品。女性科技公司也利用用户资料来创建更有效、更客製化的解决方案，从而提高客户满意度和市场渗透率。

从地区来看，2024 年北美创造了 195 亿美元的收入，其中美国占比 89.2%，这主要是由于人们越来越关注女性健康，以及对可获得且负担得起的解决方案的需求不断增加。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 已开发国家利用数位科技管理妇女健康
    • 改善偏远地区妇女获得照护的机会
    • 发展中国家对女性健康和保健的认识不断提高
    • 女性人口慢性病及传染病负担加重
    • 女性科技业投资不断成长
  • 产业陷阱与挑战
    • 缺乏对女性科技产品与应用的认识
• 成长潜力分析
• 监管格局
• 技术格局
• 未来市场趋势
• 波特的分析
• PESTEL分析

第四章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 策略仪表板

第五章：市场估计与预测：按类型，2021 年至 2034 年

• 主要趋势
• 产品
• 软体
• 服务

第六章：市场估计与预测：按应用，2021 年至 2034 年

• 生殖健康
  • 月经週期和生育能力
  • 停经
• 怀孕和护理
• 骨盆腔和子宫保健
• 一般医疗保健和健康
• 其他应用

第七章：市场估计与预测：依最终用途，2021 年至 2034 年

• 主要趋势
• 直接面向消费者
• 医院
• 生育诊所
• 外科中心
• 诊断中心
• 其他最终用户

第八章：市场估计与预测：按地区，2021 年至 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 俄罗斯
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
• 拉丁美洲
  • 巴西
  • 墨西哥
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯

第九章：公司简介

• BioWink GmbH
• Athena Feminine Technologies
• Conceivable, Inc
• HeraMED
• Elvie
• iSono Health
• Nuvo Cares
• Minerva Surgical
• Prelude
• Sustain Natural
• Sera Prognostics
• Univfy
• Totohealth

The Global Femtech Market was valued at USD 60.2 billion in 2024 and is projected to expand at a CAGR of 16% between 2025 and 2034. Femtech, short for female technology, focuses on developing innovative products, services, and platforms that address women's unique healthcare needs. These include solutions for fertility, pregnancy, reproductive health, menopause, sexual wellness, and general well-being. Growing reliance on digital technologies to manage women's health, especially in developed nations, has significantly propelled market growth.

Increasing chronic conditions such as cancer, diabetes, hypertension, and mental health issues among women are fueling the demand for personalized, tech-driven healthcare. Femtech offers tailored tools that assist women in managing complex health challenges, further boosting the market. The ongoing rise in awareness around women-centric health issues and the development of wearable and mobile health devices are driving the need for accessible and targeted solutions. The integration of advanced technology into everyday healthcare for women has encouraged more women to adopt digital platforms, creating strong market momentum.

In terms of type, the femtech market was estimated at USD 60.2 billion in 2024, with the product segment contributing USD 11.5 billion and expected to register a 13.8% growth rate from 2025 to 2034. Increasing demand for personalized healthcare solutions and rapid advancements in wearable devices and mobile health technologies are enhancing product adoption. Rising awareness about pregnancy complications and the need for innovative tools for monitoring and managing women's health further support the market outlook. On the application front, femtech is divided into pregnancy and nursing care, reproductive health, pelvic and uterine healthcare, general healthcare and wellness, and others.

The reproductive health segment led the market with USD 26.4 billion in revenue in 2024, capturing a 43.9% share. Growing recognition of fertility, pregnancy, menstruation, and menopause-related health concerns, coupled with rising openness in discussing these issues, has increased demand for specialized reproductive health solutions. The incorporation of advanced wearable devices, mobile apps, and telemedicine has transformed reproductive health management, pushing the market forward.

Based on end use, the market is segmented into direct-to-consumer, hospitals, fertility clinics, surgical centers, diagnostic centers, and others. The direct-to-consumer segment accounted for USD 19.5 billion in 2024, driven by the rising preference for personalized healthcare tools accessible from home. Women are increasingly opting for products that address sensitive health needs while ensuring privacy and convenience. Femtech companies are also leveraging user data to create more effective and tailored solutions, boosting customer satisfaction and market penetration.

Regionally, North America generated USD 19.5 billion in revenue in 2024, with the U.S. accounting for 89.2% of this share, largely due to a growing focus on women's health and increasing demand for accessible and affordable solutions.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Usage of digital technology to manage women health in developed countries
    • 3.2.1.2 Improving access to women care in remote areas
    • 3.2.1.3 Growing awareness regarding women health and wellness in developing countries
    • 3.2.1.4 Increasing burden of chronic and infectious diseases among the female population
    • 3.2.1.5 Growing investments in femtech industry
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Lack of awareness about femtech products and applications
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Future market trends
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Products
• 5.3 Software
• 5.4 Services

Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

• 6.1 Reproductive health
  • 6.1.1 Menstrual cycle and fertility
  • 6.1.2 Menopause
• 6.2 Pregnancy and nursing care
• 6.3 Pelvic and uterine healthcare
• 6.4 General healthcare and wellness
• 6.5 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Direct-to-consumer
• 7.3 Hospitals
• 7.4 Fertility clinics
• 7.5 Surgical centers
• 7.6 Diagnostic centers
• 7.7 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Russia
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia

Chapter 9 Company Profiles

• 9.1 BioWink GmbH
• 9.2 Athena Feminine Technologies
• 9.3 Conceivable, Inc
• 9.4 HeraMED
• 9.5 Elvie
• 9.6 iSono Health
• 9.7 Nuvo Cares
• 9.8 Minerva Surgical
• 9.9 Prelude
• 9.10 Sustain Natural
• 9.11 Sera Prognostics
• 9.12 Univfy
• 9.13 Totohealth